Core Laboratories Inc. (NYSE:CLB) Holdings Lowered by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. lowered its stake in Core Laboratories Inc. (NYSE:CLB) by 5.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 499,299 shares of the oil and gas company’s stock after selling 30,223 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Core Laboratories were worth $8,643,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. State Street Corp grew its stake in Core Laboratories by 2.9% during the 3rd quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company’s stock valued at $36,597,000 after acquiring an additional 56,187 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Core Laboratories by 0.7% during the third quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company’s stock worth $19,521,000 after purchasing an additional 7,721 shares during the period. Boston Trust Walden Corp grew its position in Core Laboratories by 2.7% during the fourth quarter. Boston Trust Walden Corp now owns 617,336 shares of the oil and gas company’s stock valued at $10,686,000 after purchasing an additional 16,503 shares in the last quarter. Barclays PLC grew its position in Core Laboratories by 288.2% during the third quarter. Barclays PLC now owns 83,570 shares of the oil and gas company’s stock valued at $1,549,000 after purchasing an additional 62,042 shares in the last quarter. Finally, Principal Financial Group Inc. increased its stake in Core Laboratories by 3.1% in the 4th quarter. Principal Financial Group Inc. now owns 229,096 shares of the oil and gas company’s stock valued at $3,966,000 after buying an additional 6,827 shares during the period. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Stock Down 0.6 %

CLB opened at $15.31 on Monday. The business has a 50 day moving average of $16.79 and a 200-day moving average of $18.17. The stock has a market capitalization of $716.69 million, a price-to-earnings ratio of 23.19, a P/E/G ratio of 0.99 and a beta of 2.38. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49. Core Laboratories Inc. has a 1-year low of $12.95 and a 1-year high of $25.13.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. As a group, sell-side analysts anticipate that Core Laboratories Inc. will post 0.96 earnings per share for the current year.

Core Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Monday, February 10th were given a $0.01 dividend. The ex-dividend date of this dividend was Monday, February 10th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.26%. Core Laboratories’s dividend payout ratio is currently 6.06%.

Wall Street Analyst Weigh In

Separately, Citigroup raised shares of Core Laboratories from a “sell” rating to a “neutral” rating and upped their price target for the stock from $15.00 to $16.00 in a research note on Wednesday, March 12th. One research analyst has rated the stock with a sell rating and four have issued a hold rating to the company. According to MarketBeat.com, Core Laboratories presently has an average rating of “Hold” and a consensus price target of $17.50.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.